ABVC BioPharma Inc

NASDAQ:ABVC   3:42:37 PM EDT
0.58
-0.01 (-1.41%)
Products, Regulatory

ABVC BioPharma Says Phase II Vitargus Clinical Study Protocol Gets Local Ethics Committee Approval

Published: 08/02/2022 13:32 GMT
ABVC BioPharma Inc (ABVC) - Abvc Biopharma Provides Vitargus® Update.
Abvc Biopharma Inc - Phase Ii Vitargus Clinical Study Protocol Receives Local Ethics Committee Approval.
Abvc Biopharma Inc - Vitargus Phase Ii Clinical Study Protocol Documents Are Now Under Review by Australian Bellberry Human Research Ethics Committee.
Abvc Biopharma Inc - Upon Tga Approval, Clinical Trial Will Begin in Australia at Previously Selected Sites.